MetaCap

Lakewood-Amedex Biotherapeutics (LABT) vs Redhill Biopharma (RDHL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Redhill Biopharma is the larger company by market cap ($2.5 million vs $2.2 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

LABT-71.18%RDHL-40.72%
+27%-28%-83%
Oct 7, 20261 yearNov 20, 2026
LABT-68.69%RDHL-47.87%
+4%-37%-78%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

LABT versus RDHL key metrics
MetricLABTRDHL
Share price$0.2449$0.281
Market cap$2.19M$2.50M
1-day change+15.03%-13.08%
Forward P/E—9.37
EPS (TTM)$-5.57$0.00
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$8.04M
Revenue growth (YoY)—+23.17%
Net income (latest FY)—$-8.27M
Gross margin—60.31%
Operating margin—-181.69%
Net margin—-102.80%
52-week high$98.20$1.60
52-week low$0.17$0.281
Distance from 52-week high-99.75%-82.44%
Analyst consensusstrong_buy—
Avg. price target upside+4799.96%—
Average volume16.14M2.08M
Shares outstanding8.95M8.89M
Employees513
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Lakewood-Amedex Biotherapeutics

LABT stock →

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees

About Redhill Biopharma

RDHL stock →

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H.

Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees

LABT vs RDHL FAQ

Which is bigger, Lakewood-Amedex Biotherapeutics or Redhill Biopharma?

Redhill Biopharma (RDHL) is larger, with a market capitalization of $2.50M compared with $2.19M for Lakewood-Amedex Biotherapeutics (LABT).

Are Lakewood-Amedex Biotherapeutics and Redhill Biopharma in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons